Audeara strengthens commercial base as FY27 focus turns to revenue growth

Audeara's Australian wholesale revenue rose 46.4% to $2.62 million in FY26, contributing to record full-year cash receipts of $4.2 million, up 11.1% on FY25. The company advanced its AUA Technology programs across AI audio licensing, Auracast deployments, education and partner-led product development, with the first Optek AI audio customer program moving closer to commercial production. Audeara finished FY26 with cash of $740,000 and net operating cash outflows of $415,000, the lowest in its history.

Audeara strengthens commercial base as FY27 focus turns to revenue growth Audeara’s Australian wholesale revenue rose 46.4% to $2.62 million in FY26, continuing to underpin the business AUA Technology advanced across AI audio licensing, Auracast deployments, education and partner-led product development First Optek AI audio customer program moved closer to commercial production while new agreements expanded commercial pathways Special Report: Audeara’s Q4 FY26 results highlight the work done to strengthen its commercial base and expand the pathways along which its personalised hearing technology can reach customers. Australian wholesale continued to underpin operations while AUA Technology programs advanced across AI licensing, its proprietary Auracast, education and partner-led product development. For the June quarter, Audeara ASX: AUA https://stockhead.com.au/company/audeara-aua/ recorded customer receipts of $709,000, contributing to record high full-year cash receipts of $4.2m, up 11.1% on FY25. Quarterly unaudited Q4 revenue of $470,000 took FY26 revenue increased to $4.44m from ~$3.79m a year earlier. The company finished the financial year with cash and cash equivalents of $740,000 and said FY26 net operating cash outflows of $415,000 were the lowest in its history, reflecting focus on achieving consistent profitability and cash preservation. Source: Audeara Australian wholesale business continues to grow Australian wholesale remained Audeara’s core commercial engine during FY26 with revenue of $376,000 for the quarter taking the total to $2.62m from ~$1.79m in FY25, a 46.4% increase. The result was supported by repeat orders from established wholesale customers, the rollout of Audeara’s proprietary Auracast portfolio into national accounts and ongoing engagement with hearing clinics and audiology professionals. Secures exclusive Shokz deal During the quarter, Audeara secured exclusive Australian market deployment rights https://stockhead.com.au/health/audeara-secures-exclusive-shokz-deal-to-target-australias-school-listening-market/ with Shokz Health Global for a customised assistive listening product to be marketed as OpenLearn Small by Shokz Hear. The education-focused product is being developed for Australian classrooms and targets children experiencing functional listening challenges with the deal providing a pathway into government-funded education programs and charitable channels. Audeara said it supported scalable deployment through institutional procurement while maintaining a capital-efficient model and low-cost customer-acquisition costs. Rollout of Auracast starts at Bolton Clarke Audeara also commenced what it believes is a world-first rollout of Auracast technology across Bolton Clarke’s retirement living network, starting at Carrington Retirement Village in Queensland. The deployment is expected to expand across Bolton Clarke’s 43 retirement villages nationally, creating a large-scale reference site for shared listening technology in retirement communities. The rollout supports Audeara’s connected-listening strategy across aged care, healthcare and accessibility settings. Research by Bolton Clarke Research Institute indicates ~45% of residents are affected by hearing loss, impacting their ability to remain connected with their community, providing another opportunity for Audeara. Meanwhile, its Auracast program with Taiwanese partner Clinico continued progressing through product development, certification, manufacturing planning and go-to-market preparation following initial purchase orders secured earlier in the year. https://stockhead.com.au/health/audeara-lands-clinico-orders-for-three-white-label-hearing-tech-programs/ AI licensing nears commercial production During Q4 FY26 Audeara progressed under its chip-level AI audio licensing agreement with Optek Microelectronics. Audeara said the first customer program had completed its core development phase and was now close to commercial production, with final production-readiness, manufacturing and customer processes underway. A second customer program has also completed development and is progressing through final customer validation ahead of potential commercial production. Once commercial production starts, the licensing model is expected to generate fee-per-chip revenue, providing a scalable, capital-light pathway for Audeara’s technology to reach multiple products and brands without manufacturing finished hardware itself. Audeara said commercial production marked an important milestone, demonstrating its AI audio technology can move from development into semiconductor platforms through a scalable licensing model without needing to manufacture finished products or own the end-customer channel. International expansion continues Audeara also continued expanding its international presence during the June quarter through industry events and partner engagement. The company showcased its hearing accessibility and connected-listening technologies at ACAud 2026, SusHi Tech Tokyo 2026 and the Asia Summit on Global Health. In Japan, Audeara also signed distributor Pola Digital, adding another channel to support future growth across government, education, infrastructure and entertainment markets. The company said work also continued in China to refine the commercial strategy for its personalised hearing products following market testing and regulatory certification. Leadership transition as co-founder steps down During Q4 FY26, Audeara announced the transition of co-founder and chief technology officer Alex Afflick from his full-time executive role. The company said a structured handover process had been implemented to transfer technical knowledge and responsibilities across its engineering and leadership teams and acknowledged Afflick’s contribution to development of its core technology platform. Focus on commercial conversion in FY27 Audeara CEO and founder Dr James Fielding said the company had spent FY26 building multiple commercial pathways and was now focused on converting those opportunities into recurring revenue. “Entering FY27, our focus remains on commercial conversion,” he said. “We are working to turn the programs we have built on strong foundations and validated during FY26 into repeatable product, service and licensing revenue, while maintaining disciplined cash management and continuing to strengthen the Australian wholesale channel.” This article was developed in collaboration with Audeara, a Stockhead advertiser at the time of publishing. This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions. UNLOCK INSIGHTS Discover the untold stories of emerging ASX stocks. Daily news and expert analysis, it's free to subscribe. By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy https://stockhead.com.au/privacy-policy/ .